ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an ...

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company has received a Notice

Related Keywords

United States ,America ,Paulf Hickey ,Michael Miller ,Nasdaq ,Rx Communications Group ,Trademark Office ,Exchange Commission ,Shape Lifesciences ,Patent Term Extension ,Chief Executive Officer ,Reshape Lifesciences ,Diabetes Bloc Stim Neuromodulation ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Shape Lifesciences Investor Contact ,Chief Executive ,Relations Contact ,Region ,